Af­ter net­ting $200M, Syn­thego to break ground on its man­u­fac­tur­ing fa­cil­i­ty

Cal­i­for­nia-based biotech Syn­thego has been main­ly fo­cused on de­vel­op­ing CRISPR-based tools to help re­searchers in acad­e­mia and biotech, but its lat­est move now is turn­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER